Joshua Foukas Biography and Net Worth

P. Joshua Foukas serves as Chief Legal Officer, General Counsel and Corporate Secretary of the Company. Mr. Foukas joined USANA in 2007 as Associate General Counsel and served in that role until he was appointed as Vice President of Finance and Legal in 2011. He served in this finance position on an interim basis until December 2012, when he was appointed as Vice President of Legal and Investor Relations. In January 2017, he was appointed Executive Vice President of Legal and in July 2018 he was promoted to Chief Legal Officer and named Corporate Secretary. Prior to joining USANA, Mr. Foukas served as corporate counsel for a public biotech company. Prior to that, he practiced law as a corporate and securities attorney with a law firm in Salt Lake City, Utah. Mr. Foukas received a B.A. from the University of Utah and a J.D. from the University of Idaho.

What is Joshua Foukas' net worth?: The estimated net worth of Joshua Foukas is at least $132,919.56 as of February 16th, 2023. Mr. Foukas owns 3,012 shares of USANA Health Sciences stock worth more than $132,920 as of April 19th. This net worth evaluation does not reflect any other assets that Mr. Foukas may own. Additionally, Mr. Foukas receives a salary of $561,280.00 as Insider at USANA Health Sciences. Learn More about Joshua Foukas' net worth.
How old is Joshua Foukas?: Mr. Foukas is currently 48 years old. There are 7 older executives and no younger executives at USANA Health Sciences. The oldest executive at USANA Health Sciences is Dr. Myron W. Wentz, Founder & Chairman Emeritus, who is 83 years old. Learn More on Joshua Foukas' age.
What is Joshua Foukas' salary?: As the Insider of USANA Health Sciences, Inc., Mr. Foukas earns $561,280.00 per year. There are 5 executives that earn more than Mr. Foukas. The highest earning executive at USANA Health Sciences is Mr. Kevin G. Guest, Executive Chairman, who commands a salary of $1,080,000.00 per year. Learn More on Joshua Foukas' salary.
How do I contact Joshua Foukas?: The corporate mailing address for Mr. Foukas and other USANA Health Sciences executives is 3838 West Parkway Blvd, Salt Lake City UT, 84120. USANA Health Sciences can also be reached via phone at (801) 954-7100 and via email at [email protected]. Learn More on Joshua Foukas' contact information.
Has Joshua Foukas been buying or selling shares of USANA Health Sciences?: Joshua Foukas has not been actively trading shares of USANA Health Sciences during the last ninety days. Most recently, Joshua Foukas sold 3,771 shares of the business's stock in a transaction on Thursday, February 16th. The shares were sold at an average price of $61.01, for a transaction totalling $230,068.71. Following the completion of the sale, the insider now directly owns 3,012 shares of the company's stock, valued at $183,762.12. Learn More on Joshua Foukas' trading history.
Who are USANA Health Sciences' active insiders?: USANA Health Sciences' insider roster includes Robert Auciaux (Director), Jim Brown (President), John Fleming (Director), Joshua Foukas (Insider), Gilbert Fuller (Director), G. Iiekking (CFO), Daniel Macuga (Insider), David Mulham (Insider), Brent Neidig (Insider), Walter Noot (COO), Feng Peng (Director), Robert Sinnott (Insider), Myron Wentz (Major Shareholder), and Frederic Winssinger (Director). Learn More on USANA Health Sciences' active insiders.
Are insiders buying or selling shares of USANA Health Sciences?: In the last twelve months, insiders at the sold shares 20 times. They sold a total of 59,164 shares worth more than $3,449,714.61. The most recent insider tranaction occured on March, 11th when Chairman Kevin Guest sold 11,011 shares worth more than $539,539.00. Insiders at USANA Health Sciences own 0.3% of the company. Learn More about insider trades at USANA Health Sciences.
Information on this page was last updated on 3/11/2024.

Joshua Foukas Insider Trading History at USANA Health Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/16/2023	Sell	3,771	$61.01	$230,068.71	3,012
3/2/2022	Sell	3,303	$89.93	$297,038.79
10/28/2021	Sell	181	$95.17	$17,225.77
8/5/2021	Sell	249	$97.07	$24,170.43
2/11/2021	Sell	2,906	$95.02	$276,128.12
8/20/2020	Sell	270	$83.15	$22,450.50
4/23/2020	Sell	1,966	$82.49	$162,175.34
10/28/2019	Sell	1,115	$74.53	$83,100.95
10/29/2018	Sell	291	$111.34	$32,399.94
9/12/2018	Sell	306	$129.27	$39,556.62
9/6/2018	Sell	6,531	$125.79	$821,534.49	2,348

Joshua Foukas Buying and Selling Activity at USANA Health Sciences

USANA Health Sciences Company Overview

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $44.13

$43.34

$44.31

50 Day Range

MA: $47.67

$43.01

$52.36

2 Week Range

Now: $44.13

$42.59

$69.60

Volume

85,577 shs

Average Volume

79,791 shs

Market Capitalization

$849.06 million

P/E Ratio

13.37

Dividend Yield

N/A

Beta

0.91

Urgent alert: open this for a huge profit potential

From Timothy Sykes | Ad

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

See Tim’s instructions to make this remarkably simple trade right here

Joshua Foukas Biography and Net Worth

What is Joshua Foukas' net worth?

How old is Joshua Foukas?

What is Joshua Foukas' salary?

How do I contact Joshua Foukas?

Has Joshua Foukas been buying or selling shares of USANA Health Sciences?

Who are USANA Health Sciences' active insiders?

Are insiders buying or selling shares of USANA Health Sciences?